Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin
- PMID: 6180832
- DOI: 10.1016/0092-8674(82)90163-5
Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin
Abstract
A disulfide-linked conjugate between asialofetuin (ASF) and the toxic A chain (RTA) of ricin is as potent a toxin for cultured rat hepatocytes as our previously described conjugate between ASF and fragment A of diphtheria toxin (DTA). An RTA conjugate of epidermal growth factor (EGF) was a potent toxin for 3T3 cells. In contrast, EGF-DTA was essentially nontoxic for 3T3 cells. We have now examined the toxicity of EGF-RTA and EGF-DTA on cultured hepatocytes. The EGF-DTA conjugate, nontoxic to 3T3 cells, is also a potent toxin for hepatocytes. We also observed a decrease with time of culture in the sensitivity of hepatocytes to the ASF and EGF conjugates. This decrease is not a result of a decrease in EGF or asialoglycoprotein receptors.
Similar articles
-
Toxic ligand conjugates as tools in the study of receptor-ligand interactions.J Cell Biochem. 1982;20(2):163-76. doi: 10.1002/jcb.240200208. J Cell Biochem. 1982. PMID: 6188758 Review.
-
Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.Proc Natl Acad Sci U S A. 1981 Jun;78(6):3383-7. doi: 10.1073/pnas.78.6.3383. Proc Natl Acad Sci U S A. 1981. PMID: 6167984 Free PMC article.
-
Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic.Cell. 1980 Nov;22(2 Pt 2):563-70. doi: 10.1016/0092-8674(80)90366-9. Cell. 1980. PMID: 6256086
-
Study on the variables affecting toxicity of hybrid toxins. The effect of different target cell receptor distribution and toxin binding chain.Biochim Biophys Acta. 1989 Oct 9;1013(3):239-46. doi: 10.1016/0167-4889(89)90141-9. Biochim Biophys Acta. 1989. PMID: 2804085
-
Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor.J Viral Hepat. 1997;4(6):363-70. doi: 10.1046/j.1365-2893.1997.00067.x. J Viral Hepat. 1997. PMID: 9430355 Review.
Cited by
-
Targeting the EGF receptor for ovarian cancer therapy.J Oncol. 2010;2010:414676. doi: 10.1155/2010/414676. Epub 2009 Dec 28. J Oncol. 2010. PMID: 20066160 Free PMC article.
-
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.Nucleic Acid Ther. 2018 Jun;28(3):109-118. doi: 10.1089/nat.2018.0736. Epub 2018 May 24. Nucleic Acid Ther. 2018. PMID: 29792572 Free PMC article. Review.
-
Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.Pharm Res. 1989 Feb;6(2):105-18. doi: 10.1023/a:1015961424122. Pharm Res. 1989. PMID: 2668913 Review.
-
Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B.J Bacteriol. 1987 Apr;169(4):1554-63. doi: 10.1128/jb.169.4.1554-1563.1987. J Bacteriol. 1987. PMID: 3549695 Free PMC article.
-
Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate in human leukemia cell line, K562.Jpn J Cancer Res. 1990 Jan;81(1):91-9. doi: 10.1111/j.1349-7006.1990.tb02512.x. Jpn J Cancer Res. 1990. PMID: 2139019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources